Mortality trends in women and men with COPD in Ontario, Canada, 1996-2012

Thorax

Volumn 70, Issue 2, 2015, Pages 121-126

  Gershon, Andrea ^a,b,c,d   Hwee, Jeremiah ^b   Victor, J Charles ^b   Wilton, Andrew ^b   Wu, Robert ^e   Day, Anna ^c,f   To, Teresa ^b,d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSAL ATTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORTALITY; POPULATION RISK; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL STATUS; TREND STUDY; URBAN RURAL DIFFERENCE; CAUSE OF DEATH; COMORBIDITY; LONGITUDINAL STUDY; LUNG TUMOR; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRENDS;

ADULT; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; ONTARIO; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEX FACTORS;

EID: 84921407489     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205956     Document Type: Article

References (26)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
2. Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease (COPD). Lancet 2011;378:991-6.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (updated 2013). Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2013.
4. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
5. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89.
6. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28:1245-57.
7. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
8. Gershon AS, Wang C, Wilton AS, et al. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med 2010;170:560-5.
9. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2014 update: a report from the american heart association. Circulation 2014;129:e28-e292.
10. Jaro MA. Probabilistic linkage of large public health data files. Stat Med 1995;14:491-8.
11. National Center for Health Statistics (NCHS) VS. Data entry instructions for mortality medical indexing, classification, and retrieval system (MICAR). Hyattsville, Maryland: NCHS instruction manual, 2014.
12. National Center for Health Statistics (NCHS) VS. Dictionary of valid terms for the mortality medical indexing, classification, and retrieval system (MICAR). Hyattsville, Maryland: NCHS instruction manual, 2014.
13. Gershon AS, Wang C, Vasilevska-Ristovska J, et al. Identifying patients with physician diagnosed asthma in health administrative databases. Can Respir J 2009;16:183-8.
14. Plessis V, Beshiri R, Bollman R, et al. Definitions of "Rural". Ottawa: Statistics Canada, 2002.
15. Postal Code Conversion File [computer program]. Ottawa, Canada: Minister of Industry, 2009.
16. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2013. Toronto, ON: Canadian Cancer Society, 2013.
17. Reid JL, Hammond D, Rynard V, et al. Tobacco use in Canada: patterns and trends, 2014 edition. Waterloo, Ontario: Propel Centre for Population Health Impact, University of Waterloo, 2014.
18. Sorheim IC, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480-5.
19. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-505.
20. Prescott E, Bjerg AM, Andersen PK, et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997;10:822-7.
21. Kanner RE, Connett JE, Altose MD, et al. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med 1994;150:956-61.
22. Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. Respir Med 2004;98:1207-13.
23. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest 2001;119:1691-5.
24. Tu JV, Nardi L, Fang J, et al. National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ 2009;180:E118-25.
25. Hole DJ, Watt GCM, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ (Clinical research ed 1996;313:711-15.
26. Murray CJ, Richards MA, Newton JN, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013;381:997-1020.